These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Exempt, with results 2006-003678-82 Pharmacokinetics and effects of oral clonidine in children with suspected Growth Hormone deficiency 2008-12-15 not-yet-due
Ongoing 2008-004425-42 Neurocognitive testing in children with ADHD not-yet-due
Completed, but no date, and reported results 2010-020014-28 Pharmacokinetics in Plasma and Saliva of a Single Dose Immediate- or Extended Release Methylphenidate in Healthy Volunteers. bad-data
Completed, but no date, and reported results 2011-005086-20 Effects of paracetamol on nociception in adolescents. bad-data
Completed, but no date Terminated 2012-001530-34 Varenicline, a partial nicotinic receptor agonist for the treatment of Excessive Daytime Sleepiness in Parkinson’s Disease: a placebo-controlled cross-over study bad-data
Completed, but no date, and reported results 2013-000426-62 A randomized, double blind, placebo-controlled crossover study to investigate the effects of a selective serotonergic reuptake inhibitor on resting state fMRI in healthy volunteers. bad-data
Ongoing 2013-001976-39 Randomized, open-label, crossover study into the contribution of the intestines and kidney in the diurnal variation of Levofloxacin pharmacokinetics Een onderzoek naar de dag/nacht ritmes in de opn... not-yet-due
Not reported 2013-004089-33 A Phase 1, Open Label, Exploratory Study for the Intra-operative Imaging of Folate Receptor Alpha Positive Ovarian and Lung Cancer using the Tumor Specific Imaging Agent EC17 Een fase 1, open label... 2015-04-01 due-trials
Ongoing 2014-001545-25 Randomized, double-blind, placebo-controlled, three way crossover, double dummy, single centre study evaluating the effect of haloperidol 2 mg and lorazepam 1 mg on posturography and underlying system... not-yet-due
Ongoing 2014-003956-30 A single-centre randomized double-blind, double-dummy, placebo-controlled, four-way crossover study in healthy subjects to investigate the effect of ethanol 0.5 and 1.0 g/L and alprazolam 1 mg on a dr... not-yet-due
Ongoing 2015-000182-31 A randomized, double-blind, placebo-controlled, cross-over study to assess the effects of fampridine on eye movements and nerve conduction in patients with multiple sclerosis (MS) and a unilateral or ... not-yet-due
Completed, but no date, and reported results 2015-001431-20 A randomized, double blind, double-dummy placebo controlled, 3-way cross-over study to determine the test-retest reliability of, and the effect of oral retigabine and riluzole on, peripheral motor ner... bad-data
Ongoing 2015-002265-36 A randomized, double blind, crossover, placebo controlled class-room experiment to assess the pharmacodynamics and pharmacokinetics of metoprolol in healthy volunteers with different polymorphism of C... not-yet-due
Completed, but no date, and reported results 2015-005650-35 Proof-of-pharmacology clinical trial on a vaccine that elicits a protective humoral immune response against oxidized low density lipoprotein bad-data
Completed, but no date 2016-000331-41 A randomized, open-label, vehicle-controlled, parallel, dose-ranging study to assess the pharmacodynamics of topically applied Imiquimod in healthy volunteers bad-data
Completed, but no date, and reported results 2017-000084-32 A study to characterize the humoral and cellular response following simultaneous immunization with a neo-antigen (KLH) and a recall antigen (tetanus) in healthy volunteers bad-data
Reported results 2017-003105-18 A randomized, placebo-controlled, evaluator-blinded, study to assess the anti-inflammatory effects of topical erythromycin and clindamycin in patients with inflammatory facial acne 2019-05-08 due-trials
Reported results 2017-003177-34 A clinical study to assess the feasibility of measuring inhaled medication concentrations in exhaled breath condensate obtained from healthy volunteers and asthma patients and to assess the relationsh... 2019-08-20 due-trials
Exempt, with results 2018-001775-20 Immunomonitoring of tacrolimus in healthy volunteers not-yet-due
Not reported 2018-003510-41 Investigating anti-inflammatory effects of topical antibiotics in an LPS skin challenge model 2019-01-23 due-trials
Exempt, with results 2019-001771-36 Assessment of Neublastin-Induced Skin and Sensory Alterations and Headache in Healthy Subjects and Migraine Patients 2020-09-30 not-yet-due
Ongoing 2019-002383-27 An exploratory, single-center, double-blinded, healthy volunteer controlled study to characterize psoriasis patients and explore novel biomarkers for the treatment response of psoriasis with a multi-m... not-yet-due
Completed, report not yet due 2019-003558-98 Randomized, double-blind, placebo-controlled, two way crossover, single centre study evaluating the acute and chronic effect of clonazepam on cognitive tests and patient-reported outcome measures in p... 2022-06-03 not-yet-due
Not reported 2019-003567-21 A randomized, evaluator-blind, vehicle controlled, parallel group study to explore the effects of the anti-inflammatory drug prednisolone in a TLR4 and TLR7 challenge model in healthy volunteers 2021-09-07 due-trials
Reported results 2020-000686-16 Randomized, double-blind, placebo-controlled crossover study to validate finger tapping tasks for the quantification of levodopa/carbidopa effects in Parkinson’s Disease patients. 2020-11-05 due-trials
Completed, report not yet due Terminated 2020-002201-25 A two-part (observational and intervention) study to explore disease characteristics of vulvar (pre)malignancies compared to healthy volunteers 2021-10-15 not-yet-due
Reported results 2020-005595-35 A dermal inflammatory challenge study to evaluate complement activation in healthy volunteers 2021-04-16 due-trials
Completed, report not yet due 2021-005429-26 Immunological characterization of TLR-7 mediated inflammation and complement activation after prolonged Imiquimod exposure in healthy volunteers 2022-03-25 not-yet-due